Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
3SBio Inc
1530Current price
5.77 HKD
-0.12 HKD (-2.04%)
Last closed
5.83 HKD
Company
www.3sbio.com
ISIN
KYG8875G1029
Sector
Healthcare
Industry
Biotechnology
Exchange
Hong Kong Stock Exchange
Capitalization
14 467 366 035 HKD
Yield for 12 month
-18.39 %
1Y
3Y
5Y
10Y
15Y
1530
3SBio Inc., an investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally. The company provides TPIAO, a recombinant human thrombopoietin to treat chemotherapy-induced thrombopenia and immune thrombocytopenia; Cipterbin, an anti-HER2 monoclonal antibody for the treatment of HER2-positive metastatic breast cancer; TNF, pre-filled aqueous injection solution. It also offers YISAIPU, the receptor fusion tumor necrosis factor inhibitor; Mandi-minoxidil tincture, an OTC external medicine for treating hair loss; EPIAO and SEPO, an erythropoietin injection; SPARIN, an injectable low-molecular-weight heparin calcium. In addition, the company provides MN709 Minoxidil Foam and Nalfuraphine hydrochloride tablets. Further, it provides trading, project management and consultation, technology, sports, financial, investment advisory, as well as manufactures medical devices; and offers agricultural services. The company has collaboration agreements with companies, such as Toray. 3SBio Inc. was founded in 1993 and is headquartered in Shenyang, the People's Republic of China. Address: No. 3 A1, Road 10, Shenyang, China
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
61.19 HKDP/E ratio
8.2162Dividend Yield
4.32 %Current Year
+7 826 005 107 HKD
Last Year
+6 868 268 103 HKD
Current Quarter
+3 788 706 665 HKD
Last Quarter
–
Current Year
+6 650 194 582 HKD
Last Year
+5 679 209 538 HKD
Current Quarter
+3 205 677 671 HKD
Last Quarter
–
Key Figures 1530
1 year
3 years
5 years
10 years
EBITDA
2 446 118 506 HKD
Operating Margin TTM
PE Ratio
8.2162
Return On Assets TTM
5.61 %
PEG Ratio
3.3305
Return On Equity TTM
10.4 %
Wall Street Target Price
61.19 HKD
Revenue TTM
8 432 397 226 HKD
Book Value
6.11 HKD
Revenue Per Share TTM
Dividend Share
0.23 HKD
Quarterly Revenue Growth YOY
16 %
Dividend Yield
4.32 %
Gross Profit TTM
5 679 209 540 HKD
Earnings per share
–
Diluted Eps TTM
–
Most Recent Quarter
II 2023
Quarterly Earnings Growth YOY
14.6 %
Profit Margin
19.7 %
Dividend Analytics 1530
Dividend growth over 5 years
46 %Continuous growth
1 yearPayout Ratio 5 years average
20 %Dividend History 1530
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
0.25
Ex Dividend Date
22.07.2024
Forward Annual Dividend Yield
4.11 %
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation 1530
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
8.2162
Forward PE
6.7069
Enterprise Value Revenue
1.3985
Price Sales TTM
1.6677
Enterprise Value EBITDA
4.2296
Price Book MRQ
0.9273
Financials 1530
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 1530
For 52 weeks
4.73 HKD
7.86 HKD
50 Day MA
6.17 HKD
Shares Short Prior Month
–
200 Day MA
6.07 HKD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart